Author

Maria L Oyaski

Observed name: Maria L. Oyaski

Institution: Breakthrough T1D

Observed institutions: Breakthrough T1D, Metabolon (United States)

OpenAlex ID: A5061759658

Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes

2024 · Esther Latres, Carla J. Greenbaum, et al. · Diabetes · 34

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS

2019 · Tiffany A Freed, Josef Coresh, et al. · Clinical Chemistry · 25

Works count: 2

Citation count: 59

H-index: 2

I10-index: 2